Slide 7 of 30
Notes:
El estudio de las heparinas incluye una descripción del problema que motivó la investigación.
“If therapy with low-molecular-weight heparin resulted in fewer bleeding complications or more effectively prevented thromboembolic recurrences… substantial savings could be realized by avoiding or shortening hospitalization in selected patients who might be eligible for outpatient treatment with low-molecular-weight heparin.”
Gould, Michael K. MD, MSc. Dembitzer, Anne D. MD. Sanders, Gillian D. PhD. Garber, Alan M. MD, PhD. Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis. [Article]. Annals of Internal Medicine. 130(10):789-799, May 18, 1999
